| Texto completo | |
| Autor(es): |
Amaral, Vinicius C.
[1]
;
Maciel, Gustavo A. R.
[1]
;
Carvalho, Katia C.
[1]
;
Marcondes, Rodrigo R.
[1]
;
Soares, Jr., Jose Maria
[1]
;
Baracat, Edmund C.
[1]
Número total de Autores: 6
|
| Afiliação do(s) autor(es): | [1] Univ Sao Paulo, Fac Med, Disciplina Ginecol, Lab Ginecol Estrutural & Mol LIM58, BR-05508 Sao Paulo - Brazil
Número total de Afiliações: 1
|
| Tipo de documento: | Artigo Científico |
| Fonte: | General and Comparative Endocrinology; v. 189, p. 105-110, AUG 1 2013. |
| Citações Web of Science: | 5 |
| Resumo | |
In this work we have evaluated the gene expression profile of prolactin and prolactin receptor in the pituitary and the uterus of female mice with metoclopramide-induced hyperprolactinemia treated with estrogen and/or progesterone. For this purpose, 49 Swiss female mice were allocated to seven groups. Interventions: 50-day treatment with metoclopramide, progesterone and estrogen. Our results showed that in the pituitary, metoclopramide-induced hyperprolactinemia increased prolactin expression. In the castrated animals, progesterone, with or without estrogen, produced an increase in prolactin. Pituitary prolactin receptor and the estrogen and progesterone treatment were responsible for the rise in PRLR-S2. In the uterus, no differences in prolactin expression were found between the different study groups. PRLR-S1 had its expression reduced in all castrated animals as against the castrated group treated with vehicle. In the noncastrated animals, PRLR-52 rose in the metoclopramide-treated group, and, in the castrated animals, its expression diminished in all groups in relation to the vehicle-treated castrated controls. An increase in PRLR-S3 was found in the oophorectomized animals treated with a combination of estrogen and progesterone. PRLR-L rose in the oophorectomized animals treated with progesterone in isolation or in association with estrogen. These findings suggest that metoclopramide associated to progesterone or estrogen may determine an increase in pituitary prolactin and PRLR-S2 expression. The estrogen-progesterone may enhance the expression of PRLR-S3 and PRLR-L isoform of prolactin receptor. (C) 2013 Elsevier Inc. All rights reserved. (AU) | |
| Processo FAPESP: | 10/51043-3 - Efeitos da hiperprolactinemia induzida pela metoclopramida nos receptores de prolactina endometrial e hipofisaria de camundongas adultas ooforectomizadas. |
| Beneficiário: | Edmund Chada Baracat |
| Modalidade de apoio: | Auxílio à Pesquisa - Regular |